Influence of socio-economic status on Shiga toxin-producing Escherichia coli (STEC) infection incidence, risk factors and clinical features
Adams NL. et al, (2019), Epidemiology and Infection, 147
Mind the gap? The platform trial as a working environment
MORRELL L. et al, (2019), Trials, 2019, 297 - 297
Risk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention?
Morton RL. et al, (2019), Cancer Epidemiol, 61, 8 - 13
Association analyses identify 31 new risk loci for colorectal cancer susceptibility.
Law PJ. et al, (2019), Nat Commun, 10
Epidemiology and health-economic burden of urinary catheter-associated infection in English NHS hospitals: a probabilistic modelling study
Smith DRM. et al, (2019), Journal of Hospital Infection
Exploring women’s preferences for birth settings in England: A discrete choice experiment
Fletcher BR. et al, (2019), PLOS ONE, 14, e0215098 - e0215098
The challenge of antimicrobial resistance: What economics can contribute
Roope LSJ. et al, (2019), Science, 364, eaau4679 - eaau4679
A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine
Fahr P. et al, (2019), Applied Health Economics and Health Policy
Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.
Morrell L. et al, (2019), BMC health services research, 19, 198 - 198
Should I stay or should I go? A retrospective propensity score matched analysis using administrative data of hospital-at-home for older people in Scotland
TSIACHRISTAS A. et al, (2019), BMJ Open
Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
SCHLACKOW I. et al, (2019), Kidney International
Comprehensive Geriatric Assessment in hospital and hospital-at-home settings: a mixed-methods study
Gardner M. et al, (2019), Health Services and Delivery Research, 7, 1 - 206
Correction to: The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study.
Leal J. et al, (2019), Pharmacoeconomics
Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions (vol 21, pg 1033, 2018)
Wordsworth S. and Buchanan J., (2019), VALUE IN HEALTH, 22, 383 - 383
Impact of variation in Type 2 diabetes care on health outcomes and healthcare costs
Keng MJ. et al, (2019), DIABETIC MEDICINE, 36, 161 - 161
Health-related quality of life in people with type 2 diabetes participating in the LEADER trial.
Nauck MA. et al, (2019), Diabetes Obes Metab, 21, 525 - 532
Development and Use of Prediction Models for Classification of Cardiovascular Risk of Remote Indigenous Australians.
Tran-Duy A. et al, (2019), Heart Lung Circ